Literature DB >> 3297914

Gastroscopic localization of a microencapsulated KCl preparation in the human stomach.

D Y Graham, J L Smith, R D Jones, A Rakhit, V Tipnis, M E Hurley.   

Abstract

A slow release polymer-coated preparation of potassium chloride granules (Micro-K Extencaps) was initially thought not to be associated with gastric mucosal damage. Recent studies have shown that acute gastric ulcers occur with approximately the same frequency as in patients taking wax matrix KCl formulations. The development of acute gastric ulcers was not consistent with the proposed dispersion characteristics of the microencapsulated KCl preparation. The authors therefore endoscopically evaluated the dispersion characteristics of microencapsulated KCl in a double-blind, placebo-controlled study. Subjects received four capsules of Micro-K or matching placebo and endoscopy was performed 30, 60, or 120 min after each drug ingestion. The material was identified with the Olympus HM (high magnification) endoscope and then quantitatively aspirated using the 3.5-mm biopsy channel of the Pentax 34JA endoscope. Microencapsulated KCl particles dispersed poorly and were found adhering to the mucosa and to one another, as a semisolid mass, most frequently in the gastric antrum. In contrast, the placebo (ethyl cellulose) was widely dispersed throughout the stomach. The authors concluded that gastric emptying must be considered in three phases: liquids, solids, and solids which adhere to the mucosa. No unique dispersion characteristics of Micro-K Extencaps were identified, and adherence of the KCl to the gastric mucosa may explain its ability to cause occasional acute gastric ulceration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297914     DOI: 10.1016/s0016-5107(87)71562-4

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations.

Authors:  H Caplain; R Dahan; R Pamphile; J J Thebault
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

Review 2.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

3.  What is the better formulation of microencapsulated potassium chloride?

Authors:  G Simoneau; J F Bergmann; R Pamphile; C Caulin; J M Segrestaa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

Review 4.  In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms.

Authors:  Felix Schneider; Mirko Koziolek; Werner Weitschies
Journal:  Pharmaceutics       Date:  2019-08-16       Impact factor: 6.321

5.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.